These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 35073761
1. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition. Pan R, Kindler E, Cao L, Zhou Y, Zhang Z, Liu Q, Ebert N, Züst R, Sun Y, Gorbalenya AE, Perlman S, Thiel V, Chen Y, Guo D. mBio; 2022 Feb 22; 13(1):e0366221. PubMed ID: 35073761 [Abstract] [Full Text] [Related]
2. Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity. Case JB, Ashbrook AW, Dermody TS, Denison MR. J Virol; 2016 Aug 15; 90(16):7248-7256. PubMed ID: 27252528 [Abstract] [Full Text] [Related]
3. Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses. Lu Y, Cai H, Lu M, Ma Y, Li A, Gao Y, Zhou J, Gu H, Li J, Gu J. J Virol; 2020 Jul 30; 94(16):. PubMed ID: 32461321 [Abstract] [Full Text] [Related]
4. Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice. Zhang Z, Liu Q, Sun Y, Li J, Liu J, Pan R, Cao L, Chen X, Li Y, Zhang Y, Xu K, Guo D, Zhou L, Lan K, Chen Y. Emerg Microbes Infect; 2021 Dec 30; 10(1):1626-1637. PubMed ID: 34365904 [Abstract] [Full Text] [Related]
6. Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity. Case JB, Li Y, Elliott R, Lu X, Graepel KW, Sexton NR, Smith EC, Weiss SR, Denison MR. J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29046453 [Abstract] [Full Text] [Related]
7. Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses. Athmer J, Fehr AR, Grunewald ME, Qu W, Wheeler DL, Graepel KW, Channappanavar R, Sekine A, Aldabeeb DS, Gale M, Denison MR, Perlman S. mBio; 2018 May 01; 9(3):. PubMed ID: 29717007 [Abstract] [Full Text] [Related]
8. Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response. Becares M, Pascual-Iglesias A, Nogales A, Sola I, Enjuanes L, Zuñiga S. J Virol; 2016 Jun 01; 90(11):5399-5414. PubMed ID: 27009949 [Abstract] [Full Text] [Related]
10. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. Selvaraj C, Dinesh DC, Panwar U, Abhirami R, Boura E, Singh SK. J Biomol Struct Dyn; 2021 Aug 01; 39(13):4582-4593. PubMed ID: 32567979 [Abstract] [Full Text] [Related]
11. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase. Ahmed-Belkacem R, Sutto-Ortiz P, Guiraud M, Canard B, Vasseur JJ, Decroly E, Debart F. Eur J Med Chem; 2020 Sep 01; 201():112557. PubMed ID: 32563813 [Abstract] [Full Text] [Related]
12. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes. Ornelas MY, Thomas AY, Johnson Rosas LI, Scoville RO, Mehta AP. ACS Synth Biol; 2022 Nov 18; 11(11):3759-3771. PubMed ID: 36331143 [Abstract] [Full Text] [Related]
14. Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis. Wang Y, Sun Y, Wu A, Xu S, Pan R, Zeng C, Jin X, Ge X, Shi Z, Ahola T, Chen Y, Guo D. J Virol; 2015 Aug 18; 89(16):8416-27. PubMed ID: 26041293 [Abstract] [Full Text] [Related]
15. Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase. Chen Y, Tao J, Sun Y, Wu A, Su C, Gao G, Cai H, Qiu S, Wu Y, Ahola T, Guo D. J Virol; 2013 Jun 18; 87(11):6296-305. PubMed ID: 23536667 [Abstract] [Full Text] [Related]
16. Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases. Hausdorff M, Delpal A, Barelier S, Nicollet L, Canard B, Touret F, Colmant A, Coutard B, Vasseur JJ, Decroly E, Debart F. Eur J Med Chem; 2023 Aug 05; 256():115474. PubMed ID: 37192550 [Abstract] [Full Text] [Related]
17. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3. Schindewolf C, Lokugamage K, Vu MN, Johnson BA, Scharton D, Plante JA, Kalveram B, Crocquet-Valdes PA, Sotcheff S, Jaworski E, Alvarado RE, Debbink K, Daugherty MD, Weaver SC, Routh AL, Walker DH, Plante KS, Menachery VD. J Virol; 2023 Feb 28; 97(2):e0153222. PubMed ID: 36722972 [Abstract] [Full Text] [Related]